Market Cap 7.40M
Revenue (ttm) 0.00
Net Income (ttm) -13.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 16,000
Avg Vol 54,666
Day's Range N/A - N/A
Shares Out 2.75M
Stochastic %K 23%
Beta 1.01
Analysts Sell
Price Target $25.00

Company Profile

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells. Its oncology pipeline includes NGC-Cap (PCS6422), a combination of PCS6422 and capecitabine, whi...

Industry: Biotechnology
Sector: Healthcare
Phone: 772 453 2899
Fax: 443 288 4420
Address:
601 21st Street, Suite 300, Vero Beach, United States
skyrockets_Inc
skyrockets_Inc May. 12 at 8:20 PM
$PCSA #4 needs to happen ASAP
1 · Reply
Tetoooo
Tetoooo May. 11 at 8:34 PM
$PCSA Q1 10-Q 🚨 • Cash: ~$1.65M left (was $5.5M) • Q1 burn: $3.6M, up 33% YoY • Raised only $244K this quarter • $60K loss on “digital assets” — they actually bought crypto • Runway: 6-8 weeks Financing is imminent. Watch the 8-K for investor names — that’s the tell. NFA​​​​​​​​​​​​​​​​
1 · Reply
skyrockets_Inc
skyrockets_Inc May. 11 at 7:40 PM
$PCSA Continuing to hold tightly in range of 100 and 50 day SMA
0 · Reply
SDBiotechInvestor
SDBiotechInvestor May. 11 at 5:57 PM
$PCSA - World Cup is 4 weeks away. Dreyfus/Chiliz continues to pump US sports on their socials. We should find out his LT plan with the PCSA ticker imminently.
0 · Reply
skyrockets_Inc
skyrockets_Inc May. 11 at 5:44 PM
$PCSA Which news come first? Crypto pivot ? Phase 2 6422 Breast Cancer trial results? What if it's something off the wall like partnership or asset sale of PCS499 or PCS12852? Only time will tell, and we all know that time is ASAP (i.e. days to weeks)
3 · Reply
Jwa68
Jwa68 May. 10 at 1:37 PM
$PCSA They publicly disclosed they will need to raise money in the next 2 plus weeks or so. Time is ticking and of the essence. Current liabilities exceed cash by about $200K as of March 31. It is likely notably worse now. Insiders appear to have been taking a small pittance of their egregious nearly$2M in salaries and trying to keep things afloat. Pay me$400K, I will gladly buy a few thousand in stock to keep the dream alive and ensure my own pay. Better, the Form 4 filings may even facilitate some increased liquidity to leverage the ATM, like in April ironocally for over 50k shares. Some here are betting on a "pump" their words not mine, based on a possible crypto pivot. The low share count at the hands of two reverse splits in the last couple years or so make it quite feasible. Unfortunately, the possible impediment to it being of substance and prolonged is that everyone knows they will quickly try to raise money off of it. Paramount to a quick game of musical chairs..DYDD
0 · Reply
SDBiotechInvestor
SDBiotechInvestor May. 8 at 2:59 PM
0 · Reply
SDBiotechInvestor
SDBiotechInvestor May. 8 at 1:28 PM
$PCSA As of today, the company has 2x more CHZ than USD in the bank. Technically, they can liquidate their CHZ at any moment for USD (and extend runway into early July) but they aren't. Dreyfus has alluded to imminent "US Ventures." It has been a long wait, but given their USD runway news is clearly as soon as Monday
1 · Reply
Jwa68
Jwa68 May. 8 at 3:58 AM
$PCSA $1.7M cash $2M liabilities. "We have financed our operations primarily through equity issuances, including a private offering on February 17, 2026 where we sold 86,956 shares of our common stock to an accredited investor in a private placement transaction for $200,000. On March 31, 2026, certain directors, officers, and employees purchased 17,796 shares of common stock for approximately $45,000. They also purchased 22,008 shares of common stock for approximately $62,000 during the month ended April 30, 2026. In April 2026, we also sold 50,330 shares of common stock under our ATM Offering for approximately $157,000 in net proceeds. We will continue to be dependent upon equity and/or debt financing until we are able to generate positive cash flows from its operations. At March 31, 2026, we had cash and cash equivalents totaling $1.7 million. Together with the $219,000 we raised in April 2026, we believe we will need to raise additional capital in the second quarter of 2026"
2 · Reply
Jwa68
Jwa68 May. 8 at 3:45 AM
$PCSA Just as was speculated. Company was in fqct hitting the ATM and diluting. In April 2026, we also sold 50,330 shares of common stock under our ATM Offering for approximately $157,000 in net proceeds. We will continue to be dependent upon equity and/or debt financing until we are able to generate positive cash flows from its operations.
0 · Reply
Latest News on PCSA
Processa Pharmaceuticals provides update on Phase 2 NGS-Cap

2025-12-17T13:05:52.000Z - 5 months ago

Processa Pharmaceuticals provides update on Phase 2 NGS-Cap


Processa Pharmaceuticals Inc trading halted, news pending

2025-12-17T00:50:10.000Z - 5 months ago

Processa Pharmaceuticals Inc trading halted, news pending


Processa Pharmaceuticals Transcript: Status Update

Jul 9, 2025, 4:15 PM EDT - 10 months ago

Processa Pharmaceuticals Transcript: Status Update


Processa terminates license agreement for PCS3117

2025-07-01T13:10:33.000Z - 11 months ago

Processa terminates license agreement for PCS3117


Processa Pharmaceuticals Provides Portfolio and Business Update

Jul 1, 2025, 9:00 AM EDT - 11 months ago

Processa Pharmaceuticals Provides Portfolio and Business Update


Processa sells 28M shares at 25c in public offering

2025-06-17T16:35:07.000Z - 11 months ago

Processa sells 28M shares at 25c in public offering


Processa sees 28M shares at 25c in public offering

2025-06-17T16:30:08.000Z - 11 months ago

Processa sees 28M shares at 25c in public offering


Processa Pharmaceuticals prices $5M at-the-market offering

2025-01-28T12:21:04.000Z - 1 year ago

Processa Pharmaceuticals prices $5M at-the-market offering


Processa Pharmaceuticals Earnings Call Transcript: Q4 2022

Mar 30, 2023, 2:30 AM EDT - 3 years ago

Processa Pharmaceuticals Earnings Call Transcript: Q4 2022


skyrockets_Inc
skyrockets_Inc May. 12 at 8:20 PM
$PCSA #4 needs to happen ASAP
1 · Reply
Tetoooo
Tetoooo May. 11 at 8:34 PM
$PCSA Q1 10-Q 🚨 • Cash: ~$1.65M left (was $5.5M) • Q1 burn: $3.6M, up 33% YoY • Raised only $244K this quarter • $60K loss on “digital assets” — they actually bought crypto • Runway: 6-8 weeks Financing is imminent. Watch the 8-K for investor names — that’s the tell. NFA​​​​​​​​​​​​​​​​
1 · Reply
skyrockets_Inc
skyrockets_Inc May. 11 at 7:40 PM
$PCSA Continuing to hold tightly in range of 100 and 50 day SMA
0 · Reply
SDBiotechInvestor
SDBiotechInvestor May. 11 at 5:57 PM
$PCSA - World Cup is 4 weeks away. Dreyfus/Chiliz continues to pump US sports on their socials. We should find out his LT plan with the PCSA ticker imminently.
0 · Reply
skyrockets_Inc
skyrockets_Inc May. 11 at 5:44 PM
$PCSA Which news come first? Crypto pivot ? Phase 2 6422 Breast Cancer trial results? What if it's something off the wall like partnership or asset sale of PCS499 or PCS12852? Only time will tell, and we all know that time is ASAP (i.e. days to weeks)
3 · Reply
Jwa68
Jwa68 May. 10 at 1:37 PM
$PCSA They publicly disclosed they will need to raise money in the next 2 plus weeks or so. Time is ticking and of the essence. Current liabilities exceed cash by about $200K as of March 31. It is likely notably worse now. Insiders appear to have been taking a small pittance of their egregious nearly$2M in salaries and trying to keep things afloat. Pay me$400K, I will gladly buy a few thousand in stock to keep the dream alive and ensure my own pay. Better, the Form 4 filings may even facilitate some increased liquidity to leverage the ATM, like in April ironocally for over 50k shares. Some here are betting on a "pump" their words not mine, based on a possible crypto pivot. The low share count at the hands of two reverse splits in the last couple years or so make it quite feasible. Unfortunately, the possible impediment to it being of substance and prolonged is that everyone knows they will quickly try to raise money off of it. Paramount to a quick game of musical chairs..DYDD
0 · Reply
SDBiotechInvestor
SDBiotechInvestor May. 8 at 2:59 PM
0 · Reply
SDBiotechInvestor
SDBiotechInvestor May. 8 at 1:28 PM
$PCSA As of today, the company has 2x more CHZ than USD in the bank. Technically, they can liquidate their CHZ at any moment for USD (and extend runway into early July) but they aren't. Dreyfus has alluded to imminent "US Ventures." It has been a long wait, but given their USD runway news is clearly as soon as Monday
1 · Reply
Jwa68
Jwa68 May. 8 at 3:58 AM
$PCSA $1.7M cash $2M liabilities. "We have financed our operations primarily through equity issuances, including a private offering on February 17, 2026 where we sold 86,956 shares of our common stock to an accredited investor in a private placement transaction for $200,000. On March 31, 2026, certain directors, officers, and employees purchased 17,796 shares of common stock for approximately $45,000. They also purchased 22,008 shares of common stock for approximately $62,000 during the month ended April 30, 2026. In April 2026, we also sold 50,330 shares of common stock under our ATM Offering for approximately $157,000 in net proceeds. We will continue to be dependent upon equity and/or debt financing until we are able to generate positive cash flows from its operations. At March 31, 2026, we had cash and cash equivalents totaling $1.7 million. Together with the $219,000 we raised in April 2026, we believe we will need to raise additional capital in the second quarter of 2026"
2 · Reply
Jwa68
Jwa68 May. 8 at 3:45 AM
$PCSA Just as was speculated. Company was in fqct hitting the ATM and diluting. In April 2026, we also sold 50,330 shares of common stock under our ATM Offering for approximately $157,000 in net proceeds. We will continue to be dependent upon equity and/or debt financing until we are able to generate positive cash flows from its operations.
0 · Reply
skyrockets_Inc
skyrockets_Inc May. 8 at 12:01 AM
$PCSA Still spending cash on breast cancer 6422 trial but also using 500k of cash to buy more CHZ coin. Color me intrigued.... Perhaps P2 data will still drop on 6422 and funds will be raised on punp prior to a crypto pivot announcement.....either way w cash position left we are down to weeks, if not days, for an announcement imo.
1 · Reply
Goldengun23
Goldengun23 May. 7 at 9:10 PM
$PCSA 10-q out
2 · Reply
skyrockets_Inc
skyrockets_Inc May. 7 at 6:11 PM
$PCSA The Dreyfus/Chiliz theory explain via AI
0 · Reply
skyrockets_Inc
skyrockets_Inc May. 7 at 5:34 PM
$PCSA Technicals look like major price action about to happen. 50daySMA (blue) about to cross 100daySMA (red). Last time they converged this way was Oct2025 and stock went from ~5/share to ~15/share. With expected news soon coming (either cancer data or crypto pivot), the set up is prime for an explosive movement soon.
0 · Reply
SDBiotechInvestor
SDBiotechInvestor May. 7 at 4:27 PM
0 · Reply
SDBiotechInvestor
SDBiotechInvestor May. 7 at 4:24 PM
$PCSA - Can't help but feel news is close. World Cup ~ 4 weeks out.
0 · Reply
skyrockets_Inc
skyrockets_Inc May. 6 at 8:43 PM
$PCSA 10Q should be out by next week. Looking forward to reviewing cash position and burn.
0 · Reply
Jwa68
Jwa68 May. 6 at 11:30 AM
$PCSA Know what you own. A man is only as good as his word...
1 · Reply
SDBiotechInvestor
SDBiotechInvestor May. 5 at 1:20 PM
$PCSA Almost show time!
2 · Reply
Tetoooo
Tetoooo May. 5 at 1:55 AM
$PCSA we might have a chance like $CNSP from 2.50 to over 10
1 · Reply
Tetoooo
Tetoooo May. 4 at 9:35 PM
$PCSA we ll know very soon :) pump and dump or pump pump pump then dumps or pure dump from here
1 · Reply
skyrockets_Inc
skyrockets_Inc May. 4 at 2:51 PM
$PCSA The auto-buys seem pre-programmed to occur every 2 weeks. Seems to me to be more about tip-toeing in vs. 'optics'. Also, they are using the ATM to purchase. If they just need money to 'keep the lights on' they can sell through the ATM to regular retail investors...why waste their own money purchasing shares? Something doesn't add up here. Good news is only ~2 weeks and we should get be getting 10Q. There we will be able to see how much cash they really have and if they are in desperate need of cash or just loading up personal shares.
1 · Reply